baber/WOPTO huggingface dataset:
Patent NZ-535199-A (NZ)
Title: Use of an inhibitor or antagonist against tissue factor
Inventor: KORSGREN OLLE
IPC: C07K16/28
Filed: 2003-02-21
Abstract: Use of an inhibitor or antagonist against tissue factor, TF, is described to be for the treatment or prevention of diabetes or diabetes related diseases. The inhibitor or antagonist binds to or enters insulin-producing cells and inhibits production and/or release of TF from the cells. The inhibitor or antagonist is an agent which completely or partially inhibits TF productions, such as an antibody or an antisense construct acting on the TF gene including L-arginin, pyrithione, pentoxifylline and cyclosporine A.
Patent NZ-535532-A (NZ)
Title: Programming interface for licensing of software
Inventor: GUNYAKTI CAGLAR
IPC: A01K87/00
Filed: 2004-09-23
Abstract: A software licensing Application Programming Interface (API) that allows software products to use the license management functionality of a common service. A license specifies rights in a software product. The software product calls a consume method on the API in order to consume a right. If the right exists, the service binds the right to the license in which the right is found. The software product enforces the terms of the license by granting, or denying, access to some or all features depending on whether a valid instance of the right is found. Arbitrary data can be associated with a right. The API includes a method to retrieve data from a right that has been previously bound by the consume method.
Patent NZ-536868-A (NZ)
Title: Simplified preparation of complex interative DVD
Inventor: GREEN STUART
IPC: G09B7/00
Filed: 2003-04-29
Abstract: An authoring method for creating an audiovisual product. The method has three main stages. The first stage defines components implicitly representing functional sections of audiovisual content and transitions that represent movements between components (201). The second stage expands the components and transitions to provide a set of explicitly realised AV assets (120) and an expanded intermediate datastructure of nodes (110) and links (132, 134). Each node (110) is associated with one of the AV assets (120) and the links (132, 134) represent movement from one node (110) to another. The third stage creates the audiovisual product in a predetermined output format, using the AV assets (120) and the expanded intermediate datastructure of the nodes (110) and the links (132, 134).
Patent NZ-538340-A (NZ)
Title: Beta-lactamase inhibitor prodrug
Inventor: MARFAT ANTHONY
IPC: C07D499/00
Filed: 2003-08-11
Abstract: Disclosed are prodrugs of 6-beta-hydroxymethylpenicillanic acid sulfone having the formula I wherein R is H or methyl. The disclosed prodrugs are useful as beta-lactamase inhibitors and are therefore useful for the increasing of effectiveness of beta-lactam antibiotics.
Patent NZ-539411-A (NZ)
Title: Fabric with three vertically stacked wefts with twinned forming wefts
Inventor: ROUGVIE DAVID S
IPC: D21F1/00
Filed: 2003-10-14
Abstract: A papermaker's fabric, usable in the forming section of a paper machine, has three layers of cross-machine-direction (CD) wefts. The forming layer wefts are grouped into pairs. This twinning of the top-layer wefts results in non-equal spacing in the forming layer. This spacing imparts a desired non-uniformity in the web-supporting surface, thereby reducing the fabric diagonal problem. One of the top-layer wefts in each pair is vertically stacked with the middle and wear side layer wefts. The other top-layer wefts in each pair are un-stacked. This alignment increases the drainage properties of the fabric. The middle layer wefts provide extra stability in the CD.
Patent NZ-544674-A (NZ)
Title: Substituted arylthiourea derivatives useful as inhibitors of viral replication
Inventor: PHADKE AVINASH
IPC: A61K31/44
Filed: 2004-07-08
Abstract: Disclosed is a substituted arylthiourea of formula I or a pharmaceutically acceptable salt thereof, wherein z is 0, 1, or 2; R is hydrogen, methyl, or ethyl; A1 is nitrogen or CR1, A2 is nitrogen or CR2, A3 is nitrogen or CR3, A4 is nitrogen or CR4, or A5 is nitrogen or CR5; where one or none of A1-5 is nitrogen and the rest are CR1-5 and the rest of the substituents are disclosed within the specification. Also disclosed is the use of the above compound in the manufacture of a medicament for treating Hepatitis C infections.
Patent NZ-546288-A (NZ)
Title: Adjustable deburring tool
Inventor: HECHT GIL
IPC: B23B29/034
Filed: 2004-09-22
Abstract: An adjustable deburring tool having a longitudinal axis of rotation A and comprising a cutting head 12 adjustably coupled to a shank 14, the cutting head 12 comprising an insert pocket 18, a front face and a rear face with a ridge 28 projecting from the rear face, the ridge 28 having a recessed portion 30, the shank 14 having a groove communicating with an open ended and open sided threaded adjusting bore 36, the ridge 28 being slidably located in the groove with an adjusting screw screw-threaded in the threaded adjusting bore 36 and partially located in the recessed portion 30 of the ridge 28, characterized in that the cutting head 12 is provided with two axially extending oval shaped through bores 40 and the shank 14 is provided with two corresponding axially extending threaded securing bores that open out to a front face of the shank 14 and that the cutting head 12 is secured to the shank 14 by means of two securing screws that are located in the through bores 40 and screw threaded in the threaded securing bores.
Patent NZ-547457-A (NZ)
Title: Cured in place liner with integral inner impermeable layer and continuous method of manufacture
Inventor: DRIVER FRANKLIN THOMAS
IPC: B29C63/06
Filed: 2004-11-03
Abstract: A continuous length of a cured in place liner 21 having at least one layer of resin impregnable material 23 and an impermeable layer 22 bonded thereto, comprising a liner 21 formed by providing a length of a resin impregnable material 23 having an impermeable layer 22 bonded to one surface and formed into a tube with the impermeable layer 22 on the outside, wherein the longitudinal edges of the length of material joined together and sealed to form a tubular member that is everted so that the outer layer of the liner 21 is the resin impregnable material 23.
Patent NZ-550498-A (NZ)
Title: Coating of a polymer layer using low power pulsed plasma in a plasma chamber of a large volume
Inventor: COULSON STEPHEN RICHARD
IPC: B05D7/24
Filed: 2005-03-11
Abstract: Disclosed is a method for depositing a polymeric material onto a substrate, said method comprising introducing a monomeric material in a gaseous state into a plasma deposition chamber in which a plasma zone has a volume of at least 0.5 m3, igniting a glow discharge within said chamber, and applying a voltage as a pulsed field, at a power from 0.001 to 500 W/cm3 for a sufficient period of time to allow a polymeric layer to form on the surface of the substrate. Also disclosed is an apparatus for depositing a polymeric material onto a substrate, said apparatus comprising a plasma deposition chamber, at least two electrodes arranged so as to ignite a plasma within the chamber, a pump system arranged to feed monomer gas into the chamber, and power control means programmed to pulse power supplied to the electrodes so as to produce a plasma at a power of from 0.001 to 500W/m3 within a plasma zone within the chamber, said plasma zone having a volume of at least 0.5 m3.
Patent NZ-551164-A (NZ)
Title: Keystroke monitoring apparatus and method
Inventor: LYNESS ADAM RAMSAY
IPC: G06F11/34
Filed: 2005-07-08
Abstract: An apparatus (3) for recording keystrokes includes non-volatile memory (10) and a processor configured to store keystrokes received from a user input device in the non-volatile memory, to generate time stamps in response to receipt of specific keystroke events and to store the generated time stamps in the non-volatile memory, to create a record of keystrokes and associated time stamps.
Patent NZ-553752-A (NZ)
Title: Wound dressing composition comprising a cellulse ethan and a gellan sum and one or more protease inhibitors of the Serpin family
Inventor: SCHMIDT ROLAND
IPC: A61K9/19
Filed: 2005-10-04
Abstract: Discloses a wound dressing composition comprising a cellulose ether, a gellan gum and one or more protease inhibitors of the Serpin family. Further disclosed are methods of making a wound dressing composition thereof or wound dressing packages comprising said wound dressing compositions.
Patent NZ-554725-A (NZ)
Title: Anti-ADDL antibodies and uses thereof
Inventor: ACTON PAUL
IPC: A61K39/395
Filed: 2005-10-21
Abstract: Disclosed is an antibody that differentially recognizes multi-dimensional conformations of Abeta-derived diffusible ligands, also known as ADDLs. The antibody can distinguish between Alzheimer's Disease and control human brain extracts and is useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The antibody can also block binding of ADDLs to neurons, assembly of ADDLs, and tauphosphorylation and is useful in methods for preventing and treating diseases associated with soluble oligomers of amyloid beta 1-42.
Patent NZ-562203-A (NZ)
Title: Flow path conditioner system utilising an antimicrobial aqueous solvent composition
Inventor: NEAS EDWIN DEAN
IPC: A01N25/02
Filed: 2006-04-06
Abstract: Disclosed is a method of reducing a number of viable microorganisms in a flow path of a microfluidic device, comprising the steps of: a) flowing an amount of an antimicrobial composition within said flow path of a microfluidic device, wherein said antimicrobial composition comprises: i. an amount of water; ii. an amount of alcohol (such as methanol, ethanol, n-propanol, isopropanol, 2-butanol, n-butanol and isobutanol) between about 25% and about 75% by volume; and iii. an amount of ketone (such as acetone, 2-butanone, cyclohexanone, 2-pentanone, 3-pentanone, 2-hexanone, 3-hexanone, methyl isobutyl ketone, cyclobutanone, and cyclopentanone) between about 5% and about 35% by volume, and wherein said amount of alcohol and said amount of ketone are miscible in said amount of water; b) contacting said number of viable microorganisms in said flow path of said microfluidic device with said antimicrobial composition; and c) reducing said number of viable microorganisms in said flow path of said microfluidic device. Also disclosed is a method of reducing a number of viable microorganisms in a flow path of a microfluidic device, wherein said antimicrobial composition comprises: i. an amount of water between about 30% and about 90% by volume; and ii. an amount of diacetone alcohol (DAA) between about 10% and about 70% by volume, said amount of diacetone alcohol (DAA) is miscible in said amount of water.
Patent NZ-567995-A (NZ)
Title: Method of separating acids from chemical reaction mixtures by means of non-polar amines
Inventor: HUTTENLOCH OLIVER
IPC: C05G3/90
Filed: 2006-09-15
Abstract: Disclosed is a process for the removal of acids from reaction mixtures, comprising at least one product of value which is sparingly soluble in water, by means of at least one unpolar amine as auxiliary base that is not miscible with the product of value, comprising the following steps: a) reacting the auxiliary base with the acid with formation of a salt; b) reacting the salt formed in a) with a further base which accepts the acid with liberation of the auxiliary base and combines with the acid to be accepted from the auxiliary base to form a salt which is very readily soluble in water; c) extraction of the mixture obtained in step b) with water or an aqueous medium, where the salt of the further base dissolves in the aqueous phase and the product of value, or the solution of the product of value, in a suitable solvent and the auxiliary base form at least one separate non-aqueous phase; and d) removal by distillation of at least part of any solvent present from the at least one non-aqueous phase obtained in step c), to form two non-miscible liquid phases.
Patent NZ-568594-A (NZ)
Title: Novel fused pyrrole derivatives for inhibition of chymase
Inventor: BANNER DAVID
IPC: C07D495/04
Filed: 2006-12-05
Abstract: The disclosure relates to fused pyrrole derivatives of formula (Ib) wherein A, Ar, R1, R2, R2' and R2'' and n are as defined in the specification, as well as physiologically acceptable salts thereof. These compounds inhibit chymase and can be used as medicaments for the therapeutic and/or prophylactic treatment of allergic, inflammatory or fibrotic diseases selected from allergy, asthma, peripheral arterial occlusive disease, critical limb ischemia, vulnerable atherosclerotic plaque patients, unstable angina, congestive heart failure, left ventricular hypertrophy, ischemia reperfusion injury, stroke, cardiomyopathy, restenosis, rheumatoid arthritis, diabetic nephropathy, irritable Bowel Disease, Crohns' disease, atherothrombosis or burns/ulcers in Diabetes/CLI. . .
Patent NZ-569561-A (NZ)
Title: Hand-held sheet material holder
Inventor: ALLAN DONALD BRYCE
IPC: B24D11/06
Filed: 2008-07-03
Abstract: A sheet material holder is disclosed. The sheet material holder includes a body that has first and second parts which are, or are capable of, being pivotally connected together to form first and second jaws. The jaws are pivotable about a pivot axis between an open and a closed configuration. In the open configuration, a sheet of material is wrapped about an outer surface of the body, and distal ends of the sheet of material are placed in an opening between portions of the jaws distal to the pivot axis. The jaws are adapted to releasably couple to one another in the closed configuration such that the sheet of material is retained about the body and the distal ends of the sheet of material are held between the jaw portions distal to the pivot axis.
Patent NZ-574644-A (NZ)
Title: Vitamin d compositions and method of administration to a human being
Inventor: VIETH REINHOLD W
IPC: A23L33/15
Filed: 2007-05-14
Abstract: Provided is a composition for application to an object surface to provide a therapeutic or nutritional amount of vitamin D in a single drop to a human being who is to suck said composition directly from said object surface. wherein said composition oomprises vitamin D and a compound selected from the group consisting of caprylic acid, caprylic monoglyceride and monocaprylin, in a liquid, biologically-acceptable oil medium, wherein the concentration of vitamin D is between 9 to 9000 mcg/ml.
Patent NZ-576762-A (NZ)
Title: Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof
Inventor: FRICK WENDELIN
IPC: A61K31/7028
Filed: 2007-10-30
Abstract: Disclosed are 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals that have sulphate groups substituted on the oxan ring. The compounds are depicted by the structures shown. The compounds also have an amide bridge connecting the phenyl and oxan-ring.
Patent NZ-583464-A (NZ)
Title: Trolley with up/down displaceable direction control wheel
Inventor: SEDDON JON GRAHAM
IPC: B62B3/02
Filed: 2008-08-19
Abstract: A trolley is disclosed. The trolley includes a trolley frame, a plurality of wheels mounted to the frame for supporting the trolley thereon, and a direction control wheel (22). The direction control wheel is connected to the frame and displaceable relative to the frame between at least three positions, the at least three positions including a ground contact position, a ground clearance position and an obstacle negotiating position. The direction control wheel is provided for controlling the direction of travel of the trolley when in the ground contact position. The direction control wheel is operably movable between the ground contact position and the ground clearance position, and independently movable between the ground contact position and the obstacle negotiating position.
Patent NZ-583671-A (NZ)
Title: Screening method for eliminating drug trial candidates based on their use of other drugs
Inventor: DALE MARK
IPC: G06F19/00
Filed: 2008-08-04
Abstract: Disclosed is a method of screening a candidate for a clinical trial. The method is performed by generating at a first computer (2) a candidate drug list comprising a list of drugs taken by a candidate. The candidate drug list is then transmitted to a second computer (1). The method also includes receiving at the first computer (2) an output indicative of the candidate's suitability for the clinical trial. A computer apparatus configured to perform this method is also disclosed.
Patent NZ-584584-A (NZ)
Title: Air oxidation hair dye application system and method for coloring hair using the same
Inventor: MASSONI JACK T
IPC: A45D7/04
Filed: 2008-10-27
Abstract: An air oxidation hair dye application system is disclosed, which comprises: a container; an air oxidation hair dye composition inside the container; and an applicator mounted on the container, wherein the applicator is in fluid communication with the inside of the container and is capable of receiving the air oxidation hair dye composition from the container, and wherein the applicator is in a form of a comb having comb teeth, wherein the comb projects from a base and has an internal manifold that receives the air oxidation hair dye composition from the container and a plurality of openings between adjacent comb teeth through which the air oxidation hair dye composition is dispensed from the applicator.
Patent NZ-586100-A (NZ)
Title: Compositions and methods for early pregnancy diagnosis using antibodies for pregancy-associated glycoproteins (PAGs)
Inventor: MATHIALAGAN NAGAPPAN
IPC: C07K16/18
Filed: 2008-12-12
Abstract: Disclosed is an antibody or fragment thereof that binds specifically to PAG4, PAG6, PAG9, PAG16, PAG17, PAG19, PAG20 and PAG21, wherein the antibody or fragment thereof comprises an amino acid sequence comprising SEQ ID NO: 1 or a sequence with at least 97% sequence identity to SEQ ID NO: 1, or an amino acid sequence comprising SEQ ID NO: 2 or a sequence with at least 92% sequence identity to SEQ ID NO: 2. Further disclosed is an antibody produced by a hybridoma deposited as ATCC Accession Number PTA-8566, or an antigen-binding fragment thereof or an isolated cell deposited under ATCC Accession Number PTA-8566, or a progeny cell thereof that produces antibody 2D9.
Patent NZ-588580-A (NZ)
Title: Novel genes involved in biosynthesis
Inventor: HANCOCK KERRY RUTH
IPC: C12N15/29
Filed: 2009-06-05
Abstract: Disclosed are isolated nucleic acid molecules and polypeptides that regulate at least one gene in the flavonoid biosynthetic pathway in a plant or at least one gene in the condensed tannin biosynthetic pathway in a plant. Also disclosed are primers and probes for said nucleic acid molecules, host cells, plants, plant cells, seeds and compositions.
Patent NZ-589684-A (NZ)
Title: Battery straps
Inventor: MACK ROBERT J
IPC: H01M50/529
Filed: 2009-06-30
Abstract: 589684 A battery comprising six battery cells 111, 112, 113, 114, 115, 116 in a two by three pattern with three cells located on either side of a dividing line, where the cells are electrically coupled in series by five straps 121, 122, 123, 124, 125 and where two of the straps cross the dividing line.
Patent NZ-589941-A (NZ)
Title: A connector clip for a mask with a pair of resiliantly flexible spring arms having the shape of a four sided loop
Inventor: GUNEY MEMDUH
IPC: A44B11/26
Filed: 2004-12-24
Abstract: Disclosed is a locking clip for removably coupling a frame and a headgear assembly of a respiratory mask assembly for delivering breathable gas to a patient. The locking clip comprises a main body providing a front portion and a rear portion, the front portion having a front end portion adapted to be inserted into a front opening of a slot of the frame and the rear portion adapted to be removably coupled to the headgear assembly. A pair of resiliently flexible spring arms with each spring arm including a finger grip portion adapted to be manually manipulated by the patient to release the locking clip from the frame, the finger grip portion being positioned rearward of the front opening of the slot when the front end portion is inserted into the slot. The main body includes a central support tab having the front end portion adapted to be inserted into the frame and a rear end portion to which each said spring arm is connected, and each spring arm extends from the rear end portion of the central support tab towards the rear portion.
Patent NZ-590049-A (NZ)
Title: A foldable expandable ceiling grid
Inventor: MIKLOSZ MARK
IPC: E04B9/06
Filed: 2009-05-20
Abstract: 590049 A preassembled grid 10 for a suspended ceiling comprising a plurality of main tees 11 and sets of cross tees 12, the main and cross tees each including a central vertical web and a lower horizontal flange extending on both sides of the web, the cross tees 12 being connected to the main tees 11 at spaced intervals along the main tees 11 in a manner that enables the cross tees 12 to be folded towards the main tees 11 and the main tees 11 to be spaced in parallel relation with a separation between adjacent main tees 11 substantially less than the length of the cross tees 12.
Patent NZ-592859-A (NZ)
Title: Multivariable antigens complexed with targeting humanized monoclonal antibody
Inventor: ZURAWSKI GERALD
IPC: C12P21/06
Filed: 2008-01-31
Abstract: Disclosed is a method for making a modular rAb.cytokine comprising: selecting one or more rAb or a functional fragment thereof that is capable of specifically binding to a target cell; combining at least one member of a cohesin-dockerin binding pair to the rAb or a functional fragment of the rAB; wherein a rAB-cohesin/dockerin is generated; attaching at least one complementary member of the cohesin-dockerin binding pair with at least one cytokine, wherein a cytokine-cohesin/dockerin is generated; and complexing the rAB-cohesin/dockerin with the cytokine-cohesin/dockerin, wherein the rAb.cytokine is generated.
Patent NZ-594597-A (NZ)
Title: Substituted piperidines as ccr3 antagonists
Inventor: GRUNDL MARC
IPC: C07D401/14
Filed: 2010-04-01
Abstract: 594597 Disclosed herein are substituted compounds of the formula 1, wherein A, R1, R2, R3 and R4 are defined as in the description. Additional disclosed is the use of said compounds as antagonists of CCR3, and pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of said compounds or a pharmaceutically acceptable salt thereof. In one embodiment said compound is 3-({ 1-[1-(4-chloro-3-methyl-benzyl)-piperidin-4-yl]-5-oxo-pyrrolidine-2-carbonyl} amino)-5-(1-methyl-1H-tetrazol-5-yl)-benzoic acid.
Patent NZ-594892-A (NZ)
Title: Therapeutic applications of activation of human antigen-presenting cells through dectin-1
Inventor: ZURAWSKI GERARD
IPC: A61K39/395
Filed: 2008-02-22
Abstract: Disclosed is the use of a Dectin-1/TLR9 activated dendritic cell in conjunction with one or more antigens for treating a disease by enhancing T cell or B cell immune responses in the manufacture of a medicament, wherein the disease is selected from viral disease, bacterial diseases, fungal diseases, protozoa diseases, parasitic diseases, tumours, autoimmune diseases, allergies or graft rejection; wherein manufacture comprises triggering a Dectin-1 receptor on a dendritic cell with a Dectin-1 specific antibody or functional fragment thereof in conjunction with one or more antigens and an activator of TLR9; wherein the anti-Dectin-1-specific antibody or functional fragment thereof is capable of activating the dendritic cell; wherein the one or more antigens are selected from the group consisting of viral antigens, bacterial antigens, fungal antigens, protozoal antigens, parasitic antigens, tumor antigens, antigens involved in autoimmune disease, antigens involved in allergy, and antigens involved in graft rejection.